65th ASH Annual Meeting & Exposition

You may search for particular presentations by typing key words, an author's name, or the title in the box below. You may specify the type of search, i.e. whether you want to see pages that contain any or all of the words you specify. The Boolean search option requires one of the keywords and, or, and not, as well as parentheses.

The search filters will allow you to restrict your search by date, session type, or abstract category and are all optional. Hold down the Ctrl key while selecting to choose more than one option in each list, or hold down the Shift key to select a range.

Search:

Restrict search results to:

Browse by Day

Wednesday, December 6, 2023
Thursday, December 7, 2023
Friday, December 8, 2023
Saturday, December 9, 2023
Sunday, December 10, 2023
Monday, December 11, 2023
Tuesday, December 12, 2023
Wednesday, December 13, 2023
Thursday, December 14, 2023
Friday, December 15, 2023

-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
denotes an abstract that is clinically relevant

No Restriction
101. Red Cells and Erythropoiesis, Excluding Iron
102. Iron Homeostasis and Biology
112. Thalassemia and Globin Gene Regulation
113. Sickle Cell Disease, Sickle Cell Trait and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational
114. Sickle cell Disease, Sickle Cell Trait and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological
201. Granulocytes, Monocytes, and Macrophages
203. Lymphocytes and Acquired or Congenital Immunodeficiency Disorders
301. Vasculature, Endothelium, Thrombosis and Platelets: Basic and Translational
311. Disorders of Platelet Number or Function: Clinical and Epidemiological
321. Coagulation and Fibrinolysis: Basic and Translational
322. Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological
331. Thrombotic Microangiopathies/Thrombocytopenias and COVID-19-related Thrombotic/Vascular Disorders: Clinical and Epidemiological
332. Thrombosis and Anticoagulation: Clinical and Epidemiological
401. Blood Transfusion
501. Hematopoietic Stem and Progenitor Cells and Hematopoiesis: Basic and Translational
503. Clonal Hematopoiesis, Aging and Inflammation
506. Bone Marrow Microenvironment
508. Bone Marrow Failure: Acquired
509. Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital
602. Myeloid Oncogenesis: Basic
603. Lymphoid Oncogenesis: Basic
604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms
605. Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms
612. Acute Lymphoblastic Leukemias: Clinical and Epidemiological
613. Acute Myeloid Leukemias: Clinical and Epidemiological
614. Acute Lymphoblastic Leukemias: Therapies, Excluding Transplantation and Cellular Immunotherapies
615. Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies
616. Acute Myeloid Leukemias: Investigational Therapies, Excluding Transplantation and Cellular Immunotherapies
617. Acute Myeloid Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis
618. Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers and Minimal Residual Disease in Diagnosis and Prognosis
621. Lymphomas: Translational—Molecular and Genetic
622. Lymphomas: Translational–Non-Genetic
623. Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological
624. Hodgkin Lymphomas and T/NK cell Lymphomas: Clinical and Epidemiological
626. Aggressive Lymphomas: Prospective Therapeutic Trials
627. Aggressive Lymphomas: Clinical and Epidemiological
631. Myeloproliferative Syndromes and Chronic Myeloid Leukemia: Basic and Translational
632. Chronic Myeloid Leukemia: Clinical and Epidemiological
634. Myeloproliferative Syndromes: Clinical and Epidemiological
636. Myelodysplastic Syndromes—Basic and Translational
637. Myelodysplastic Syndromes – Clinical and Epidemiological
641. Chronic Lymphocytic Leukemias: Basic and Translational
642. Chronic Lymphocytic Leukemia: Clinical and Epidemiological
651. Multiple Myeloma and Plasma Cell Dyscrasias: Basic and Translational
652. Multiple Myeloma: Clinical and Epidemiological
653. Multiple Myeloma: Prospective Therapeutic Trials
654. MGUS, Amyloidosis and Other Non-Myeloma Plasma Cell Dyscrasias: Clinical and Epidemiological
701. Experimental Transplantation: Basic and Translational
703. Cellular Immunotherapies: Basic and Translational
704. Cellular Immunotherapies: Early Phase and Investigational Therapies
705. Cellular Immunotherapies: Late Phase and Commercially Available Therapies
711. Cell Collection and Processing
721. Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities
722. Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution
723. Allogeneic Transplantation: Long-term Follow-up and Disease Recurrence
731. Autologous Transplantation: Clinical and Epidemiological
732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies
801. Gene Therapies
802. Chemical Biology and Experimental Therapeutics
803. Emerging Tools, Techniques and Artificial Intelligence in Hematology
901. Health Services and Quality Improvement - Non-Malignant Conditions
902. Health Services and Quality Improvement - Lymphoid Malignancies
903. Health Services and Quality Improvement –Myeloid Malignancies
904. Outcomes Research—Non-Malignant Conditions
905. Outcomes Research—Lymphoid Malignancies
906. Outcomes Research—Myeloid Malignancies
ASH-a-Palooza
Scientific Workshop on Defining Goals and Utilizing Tools for Enhancing Diversity, Equity and Inclusion (DEI) in Clinical Trials in Hematology
Scientific Workshop on Diagnostic Techniques in Classical and Malignant Hematology
Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure
Scientific Workshop on Hematology and Aging
Scientific Workshop on Mitochondria and Metabolism in Blood Cancer- From Worms to Patients
Scientific Workshop on Myeloid Development
Scientific Workshop on Therapy Resistance Mechanisms in Blood Malignancies
Scientific Workshop on Viruses in Hematology: Emerging Challenges and Therapeutic Vulnerabilities
Scientific Workshop on the Interplay between Coagulation and Malignancy
TIP1. TiP - Classical Hematology
TIP2. TiP - Transplant/Immunotherapies
TIP3. TiP - Myeloid Malignancies
TIP4. TiP - Lymphoid Malignancies (including myeloma)
Trainee Didactic Sessions

No Restriction
Research
Research - Fundamental Science
Research - Translational Research
Research - Clinical Research
Research - Clinical Research - clinical trials
Research - Clinical Research - epidemiology
Research - Clinical Research - health outcomes research
Research - Clinical Research - health disparities research
Research - Clinical Research - patient-reported outcomes
Research - Clinical Research - real-world evidence
Research - Clinical Research - registries
Research - Clinical Research - survivorship
Clinical Practice (Health Services and Quality)
Workforce
Diversity, Equity, and Inclusion (DEI)
Diseases
Diseases - Bleeding and Clotting
Diseases - Bleeding and Clotting - bleeding disorders
Diseases - Bleeding and Clotting - hemophilia
Diseases - Bleeding and Clotting - platelet disorders
Diseases - Bleeding and Clotting - thromboembolism
Diseases - Bleeding and Clotting - thrombocytopenias
Diseases - Bleeding and Clotting - thrombotic disorders
Diseases - Bleeding and Clotting - VWD
Diseases - Bone Marrow Failure Syndromes
Diseases - Bone Marrow Failure Syndromes - Acquired Marrow Failure Syndromes
Diseases - Bone Marrow Failure Syndromes - Inherited Marrow Failure Syndromes
Diseases - Bone Marrow Failure Syndromes - Aplastic Anemia
Diseases - Bone Marrow Failure Syndromes - Paroxysmal Nocturnal Hemoglobinuria
Diseases - Genetic Disorders
Diseases - Hemoglobinopathies
Diseases - Hemoglobinopathies - Sickle Cell Disease
Diseases - Hemoglobinopathies - Sickle Cell Trait
Diseases - Hemoglobinopathies - Thalassemia
Diseases - Immune Disorders
Diseases - Immune Disorders - autoimmune disorders
Diseases - Immune Disorders - autoimmune hemolytic anemia
Diseases - Immune Disorders - GVD
Diseases - Immune Disorders - GVHD
Diseases - Immune Disorders - immunodeficiency
Diseases - Immune Disorders - neutropenia
Diseases - Immune Disorders - white blood cell disorders
Diseases - Infectious Diseases
Diseases - Infectious Diseases - Viral
Diseases - Infectious Diseases - Bacterial
Diseases - Infectious Diseases - Fungal
Diseases - Infectious Diseases - Other Pathogens
Diseases - Infectious Diseases - SARS-CoV-2/COVID-19
Diseases - Lymphoid Malignancies
Diseases - Lymphoid Malignancies - Lymphoid Leukemias
Diseases - Lymphoid Malignancies - Lymphoid Leukemias - ALL
Diseases - Lymphoid Malignancies - Lymphoid Leukemias - CLL
Diseases - Lymphoid Malignancies - Lymphoid Leukemias - LGL
Diseases - Lymphoid Malignancies - Lymphomas
Diseases - Lymphoid Malignancies - Lymphomas - Hodgkin lymphoma
Diseases - Lymphoid Malignancies - Lymphomas - non-Hodgkin lymphoma
Diseases - Lymphoid Malignancies - Lymphomas - B Cell lymphoma
Diseases - Lymphoid Malignancies - Lymphomas - T Cell lymphoma
Diseases - Lymphoid Malignancies - Lymphomas - indolent lymphoma
Diseases - Lymphoid Malignancies - Lymphomas - aggressive lymphoma
Diseases - Lymphoid Malignancies - Plasma Cell Disorders
Diseases - Myeloid Malignancies
Diseases - Myeloid Malignancies - Acute Myeloid Malignancies
Diseases - Myeloid Malignancies - Acute Myeloid Malignancies - AML
Diseases - Myeloid Malignancies - Acute Myeloid Malignancies - APL
Diseases - Myeloid Malignancies - Chronic Myeloid Malignancies
Diseases - Myeloid Malignancies - Chronic Myeloid Malignancies - MDS
Diseases - Myeloid Malignancies - Chronic Myeloid Malignancies - MPN
Diseases - Myeloid Malignancies - Chronic Myeloid Malignancies - CML
Diseases - Myeloid Malignancies - Chronic Myeloid Malignancies - CMML
Diseases - Metabolic Disorders
Diseases - Metabolic Disorders - Iron Deficiency
Diseases - Metabolic Disorders - Iron Overload
Therapies
Therapies - Biological therapies
Therapies - Biological therapies - Antibody Therapy
Therapies - Biological therapies - Bispecific Antibody Therapy
Therapies - Biological therapies - Chimeric Antigen Receptor (CAR)-T Cell Therapies
Therapies - Biological therapies - Checkpoint Inhibitor
Therapies - Biological therapies - Gene Therapy
Therapies - Biological therapies - Immunotherapy
Therapies - Biological therapies - Infusion
Therapies - Biological therapies - Monoclonal Antibody Therapy
Therapies - Biological therapies - Natural Killer (NK) Cell Therapies
Therapies - Biological therapies - Transfusion
Therapies - Biological therapies - Transplantation
Therapies - Biological therapies - Vaccines
Therapies - Non-Biological therapies
Therapies - Non-Biological therapies - Anticoagulant Drugs
Therapies - Non-Biological therapies - Chemotherapy
Therapies - Non-Biological therapies - Coagulant Drugs
Therapies - Non-Biological therapies - Devices
Therapies - Non-Biological therapies - Opioids
Therapies - Non-Biological therapies - Palliative Care
Therapies - Non-Biological therapies - Pharmacology
Therapies - Non-Biological therapies - Surgical
Therapies - Non-Biological therapies - Radiation Therapy
Therapies - Combination therapy
Therapies - drug development
Therapies - drug-drug interactions
Therapies - therapy sequence
Adverse Events
Biological Processes
Biological Processes - apoptosis
Biological Processes - CHIP
Biological Processes - genomics
Biological Processes - hematopoiesis
Biological Processes - immune mechanism
Biological Processes - immunology
Biological Processes - metabolism
Biological Processes - microbiome
Biological Processes - molecular biology
Biological Processes - multi-systemic interactions
Biological Processes - pathogenesis
Technology and Procedures
Technology and Procedures - artificial intelligence (AI)
Technology and Procedures - assays
Technology and Procedures - bioinformatics
Technology and Procedures - blood banking
Technology and Procedures - cell expansion
Technology and Procedures - clinical procedures
Technology and Procedures - computational biology
Technology and Procedures - emerging technologies
Technology and Procedures - gene editing
Technology and Procedures - profiling
Technology and Procedures - imaging
Technology and Procedures - machine learning
Technology and Procedures - molecular testing
Technology and Procedures - natural language processing
Technology and Procedures - Newborn Screening
Technology and Procedures - omics technologies
Technology and Procedures - Pathology
Technology and Procedures - Serologic Tests
Study Population
Study Population - Human
Study Population - Human - adult
Study Population - Human - elderly
Study Population - Human - embryo/fetus
Study Population - Human - pediatric
Study Population - Human - neonatal
Study Population - Human - pregnant
Study Population - Human - young adult
Study Population - Animal model
Minimal Residual Disease
Maternal Health

65th ASH Annual Meeting & Exposition

Restrict search results to:

Meeting Program